Search

Your search keyword '"Stelmach R"' showing total 403 results

Search Constraints

Start Over You searched for: Author "Stelmach R" Remove constraint Author: "Stelmach R"
403 results on '"Stelmach R"'

Search Results

1. Emerging Antineoplastic Biogenic Gold Nanomaterials for Breast Cancer Therapeutics: A Systematic Review

2. Living with COPD and its psychological effects on participating in community-based physical activity in Brazil: a qualitative study. Findings from the Breathe Well group

5. Predictors and associations of the persistent airflow limitation phenotype in asthma: a post-hoc analysis of the ATLANTIS study

6. Accuracy and economic evaluation of screening tests for undiagnosed COPD among hypertensive individuals in Brazil

7. Breaking boundaries: Exploring extended pembrolizumab in first-line treatment of renal cell carcinoma with axitinib-pembrolizumab combination

8. Treatment options and outcome of metastatic renal cell carcinoma patients with brain or bone metastases - a real world evidence

9. Lipid levels, atrial fibrillation and the impact of age: Results from the LIPIDOGRAM2015 study

10. Asthma similarities across ProAR (Brazil) and U-BIOPRED (Europe) adult cohorts of contrasting locations, ethnicity and socioeconomic status

11. Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology

12. Lenvatinib plus Pembrolizumab as first-line treatment in patients with advanced renal cell carcinoma – real world data from a retrospective multi-center analysis

13. Real world evidence from a retrospective multi-center analysis for the combination immunotherapy ipilimumab and nivolumab as first-line treatment in advanced renal cell carcinoma

14. Geolocation with respect to personal privacy for the Allergy Diary app - a MASK study

17. Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA‐MeDALL hypothesis

18. Rhinitis associated with asthma is distinct from rhinitis alone:The ARIA-MeDALL hypothesis

19. Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA-MeDALL hypothesis

20. Predictors and associations of the persistent airflow limitation phenotype in asthma: a post-hoc analysis of the ATLANTIS study

21. The ARIA-MeDALL hypothesis

25. Effect of physical effort on postural balance in COPD and OSA

27. Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA‐ARIA) ‐ EIP on AHA Twinning Reference Site (GARD research demonstration project)

28. Validation of the MASK‐rhinitis visual analogue scale on smartphone screens to assess allergic rhinitis control

29. Correlation between work impairment, scores of rhinitis severity and asthma using the MASK-air ® App

30. Is diet partly responsible for differences in COVID-19 death rates between and within countries?

31. Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis – A EUFOREA‐ARIA‐EPOS‐AIRWAYS ICP statement

33. Assessment of the Control of Allergic Rhinitis and Asthma Test (CARAT) using MASK-air

34. ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle

36. Relationship Between Anti-DFS70 Autoantibodies and Oxidative Stress

37. Assessment of the Control of Allergic Rhinitis and Asthma Test (CARAT) using MASK-air

38. Changes after 12 years of follow-up severe asthma patients cohort: higher obstruction and comorbidities, but significant better quality of life.

39. Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma

40. MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation

41. Management of anaphylaxis due to COVID-19 vaccines in the elderly

42. P157 - Real world evidence from a retrospective multi-center analysis for the combination immunotherapy ipilimumab and nivolumab as first-line treatment in advanced renal cell carcinoma

43. P151 - Lenvatinib plus Pembrolizumab as first-line treatment in patients with advanced renal cell carcinoma – real world data from a retrospective multi-center analysis

44. Rivaroxaban for thromboprophylaxis after hospitalization for medical illness

45. Correction to: Is diet partly responsible for differences in COVID-19 death rates between and within countries? (Clinical and Translational Allergy, (2020), 10, 1, (16), 10.1186/s13601-020-00323-0)

46. Correction to: Is diet partly responsible for differences in COVID-19 death rates between and within countries? (Clinical and Translational Allergy, (2020), 10, 1, (16), 10.1186/s13601-020-00323-0)

47. S19 Screening for undiagnosed COPD: a comparison of screening questionnaire test performance in two countries; Breathe Well Brazil and China

49. Lipid levels, atrial fibrillation and the impact of age: Results from the LIPIDOGRAM2015 study

Catalog

Books, media, physical & digital resources